Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$85.07 - $109.69 $4,848 - $6,252
-57 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$63.18 - $85.97 $568 - $773
9 Added 18.75%
57 $4,000
Q2 2019

Aug 09, 2019

SELL
$73.52 - $88.7 $514 - $620
-7 Reduced 12.73%
48 $4,000
Q1 2019

May 09, 2019

BUY
$63.56 - $88.17 $3,495 - $4,849
55 New
55 $5,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.